,XRCC1,PARP

Kaveri Goel1, Vani Venkatappa2, Kimiko L Krieger2

  • 1Department of Pathology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL 35294, United States.

NAR cancer
|April 24, 2025
PubMed
概括

低表达的DNA修复蛋白XRCC1预测前列腺癌 (PCa) 对PARP抑制剂 (PARPis) 的反应. 这一发现将潜在的PARPi治疗扩展到更多具有低XRCC1水平的mCRPC患者.